Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 136338 | 4.5624 |
09:34 ET | 187458 | 4.7799 |
09:36 ET | 156692 | 4.7597 |
09:38 ET | 97963 | 4.724 |
09:39 ET | 197596 | 4.845 |
09:41 ET | 184578 | 4.8501 |
09:43 ET | 177603 | 4.78 |
09:45 ET | 84695 | 4.7806 |
09:48 ET | 126521 | 4.7728 |
09:50 ET | 95018 | 4.7902 |
09:52 ET | 224035 | 4.8201 |
09:54 ET | 402819 | 5 |
09:56 ET | 609415 | 4.9099 |
09:57 ET | 146477 | 4.8984 |
09:59 ET | 119978 | 4.932 |
10:01 ET | 194038 | 4.8975 |
10:03 ET | 94457 | 4.8606 |
10:06 ET | 115707 | 4.845 |
10:08 ET | 184123 | 4.8196 |
10:10 ET | 123688 | 4.75 |
10:12 ET | 122463 | 4.69 |
10:14 ET | 52929 | 4.6458 |
10:15 ET | 40561 | 4.68 |
10:17 ET | 17658 | 4.67 |
10:19 ET | 42515 | 4.7005 |
10:21 ET | 15419 | 4.675 |
10:24 ET | 44120 | 4.67 |
10:26 ET | 38177 | 4.69 |
10:28 ET | 35644 | 4.715 |
10:30 ET | 40410 | 4.7399 |
10:32 ET | 38923 | 4.79 |
10:33 ET | 33465 | 4.715 |
10:35 ET | 100632 | 4.71 |
10:37 ET | 107772 | 4.755 |
10:39 ET | 13704 | 4.725 |
10:42 ET | 21527 | 4.7201 |
10:44 ET | 85245 | 4.6988 |
10:46 ET | 46144 | 4.745 |
10:48 ET | 57327 | 4.74 |
10:50 ET | 39650 | 4.79 |
10:51 ET | 100260 | 4.785 |
10:53 ET | 59444 | 4.725 |
10:55 ET | 92967 | 4.6699 |
10:57 ET | 66846 | 4.64 |
11:00 ET | 35329 | 4.64 |
11:02 ET | 22183 | 4.66 |
11:04 ET | 35485 | 4.69 |
11:06 ET | 19562 | 4.6801 |
11:08 ET | 8669 | 4.6899 |
11:09 ET | 9250 | 4.67 |
11:11 ET | 77378 | 4.6401 |
11:13 ET | 44248 | 4.665 |
11:15 ET | 28194 | 4.67 |
11:18 ET | 1540 | 4.6701 |
11:20 ET | 26636 | 4.655 |
11:22 ET | 30864 | 4.665 |
11:24 ET | 25678 | 4.68 |
11:26 ET | 28761 | 4.7 |
11:27 ET | 38397 | 4.725 |
11:29 ET | 37585 | 4.759 |
11:31 ET | 31966 | 4.73 |
11:33 ET | 27549 | 4.715 |
11:36 ET | 14463 | 4.725 |
11:38 ET | 59124 | 4.7336 |
11:40 ET | 2800 | 4.7301 |
11:42 ET | 45651 | 4.75 |
11:44 ET | 26341 | 4.7401 |
11:45 ET | 31087 | 4.725 |
11:47 ET | 40981 | 4.71 |
11:49 ET | 21463 | 4.705 |
11:51 ET | 18133 | 4.7201 |
11:54 ET | 4851 | 4.72 |
11:56 ET | 36431 | 4.735 |
11:58 ET | 26188 | 4.715 |
12:00 ET | 21860 | 4.71 |
12:02 ET | 66569 | 4.8 |
12:03 ET | 119688 | 4.8599 |
12:05 ET | 15700 | 4.8501 |
12:07 ET | 37596 | 4.84 |
12:09 ET | 26124 | 4.8212 |
12:12 ET | 6151 | 4.8294 |
12:14 ET | 28705 | 4.785 |
12:16 ET | 117531 | 4.735 |
12:18 ET | 44748 | 4.7015 |
12:20 ET | 67497 | 4.68 |
12:21 ET | 13089 | 4.68 |
12:23 ET | 17010 | 4.685 |
12:25 ET | 6193 | 4.69 |
12:27 ET | 12133 | 4.66 |
12:30 ET | 2850 | 4.68 |
12:32 ET | 16614 | 4.66 |
12:34 ET | 38794 | 4.695 |
12:36 ET | 411593 | 4.61 |
12:38 ET | 134252 | 4.565 |
12:39 ET | 13578 | 4.5725 |
12:41 ET | 5834 | 4.57 |
12:43 ET | 18725 | 4.57 |
12:45 ET | 1819 | 4.545 |
12:48 ET | 8913 | 4.57 |
12:50 ET | 4546 | 4.565 |
12:52 ET | 4676 | 4.565 |
12:54 ET | 7706 | 4.565 |
12:56 ET | 9393 | 4.5601 |
12:57 ET | 50705 | 4.5685 |
12:59 ET | 2000 | 4.565 |
01:01 ET | 10626 | 4.565 |
01:03 ET | 17089 | 4.565 |
01:06 ET | 24756 | 4.575 |
01:08 ET | 30502 | 4.58 |
01:10 ET | 3385 | 4.5901 |
01:12 ET | 25591 | 4.6001 |
01:14 ET | 15082 | 4.6001 |
01:15 ET | 20643 | 4.615 |
01:17 ET | 15804 | 4.6 |
01:19 ET | 1680 | 4.5901 |
01:21 ET | 37886 | 4.5701 |
01:24 ET | 8406 | 4.5801 |
01:26 ET | 6789 | 4.5801 |
01:28 ET | 4482 | 4.5801 |
01:30 ET | 925 | 4.59 |
01:32 ET | 1988 | 4.58 |
01:33 ET | 19181 | 4.575 |
01:35 ET | 24003 | 4.585 |
01:37 ET | 8500 | 4.585 |
01:39 ET | 9149 | 4.5701 |
01:42 ET | 8970 | 4.58 |
01:44 ET | 6942 | 4.565 |
01:46 ET | 7090 | 4.5612 |
01:48 ET | 3214 | 4.5601 |
01:50 ET | 947 | 4.565 |
01:51 ET | 7804 | 4.57 |
01:53 ET | 5440 | 4.57 |
01:55 ET | 64853 | 4.6 |
01:57 ET | 53033 | 4.6688 |
02:00 ET | 38021 | 4.66 |
02:02 ET | 136193 | 4.715 |
02:04 ET | 55075 | 4.7001 |
02:06 ET | 44815 | 4.7175 |
02:08 ET | 16309 | 4.6401 |
02:09 ET | 43522 | 4.69 |
02:11 ET | 24504 | 4.696 |
02:13 ET | 6587 | 4.685 |
02:15 ET | 18707 | 4.6212 |
02:18 ET | 9677 | 4.645 |
02:20 ET | 1006 | 4.645 |
02:22 ET | 4272 | 4.6518 |
02:24 ET | 33678 | 4.6183 |
02:26 ET | 23187 | 4.58 |
02:27 ET | 18097 | 4.6055 |
02:29 ET | 4715 | 4.575 |
02:31 ET | 4968 | 4.5899 |
02:33 ET | 1113 | 4.585 |
02:36 ET | 10031 | 4.6 |
02:38 ET | 2600 | 4.595 |
02:40 ET | 4977 | 4.59 |
02:42 ET | 13060 | 4.59 |
02:44 ET | 26211 | 4.635 |
02:45 ET | 7612 | 4.645 |
02:47 ET | 115928 | 4.535 |
02:49 ET | 9466 | 4.5423 |
02:51 ET | 3013 | 4.525 |
02:54 ET | 23181 | 4.53 |
02:56 ET | 36598 | 4.505 |
02:58 ET | 10762 | 4.53 |
03:00 ET | 17236 | 4.555 |
03:02 ET | 18608 | 4.565 |
03:03 ET | 24040 | 4.57 |
03:05 ET | 13200 | 4.565 |
03:07 ET | 23177 | 4.6 |
03:09 ET | 61042 | 4.615 |
03:12 ET | 25237 | 4.665 |
03:14 ET | 29225 | 4.6 |
03:16 ET | 27306 | 4.6 |
03:18 ET | 19466 | 4.58 |
03:20 ET | 15320 | 4.6 |
03:21 ET | 13035 | 4.565 |
03:23 ET | 6923 | 4.56 |
03:25 ET | 6764 | 4.575 |
03:27 ET | 12227 | 4.575 |
03:30 ET | 8214 | 4.585 |
03:32 ET | 6120 | 4.575 |
03:34 ET | 10509 | 4.585 |
03:36 ET | 45571 | 4.635 |
03:38 ET | 17177 | 4.6201 |
03:39 ET | 32649 | 4.5801 |
03:41 ET | 13797 | 4.59 |
03:43 ET | 42590 | 4.595 |
03:45 ET | 25638 | 4.545 |
03:48 ET | 27512 | 4.54 |
03:50 ET | 37415 | 4.525 |
03:52 ET | 17874 | 4.52 |
03:54 ET | 95036 | 4.505 |
03:56 ET | 139103 | 4.4888 |
03:57 ET | 39732 | 4.485 |
03:59 ET | 61951 | 4.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 300.1M | -231.7x | --- |
2Seventy Bio Inc | 244.7M | -1.1x | --- |
Chromadex Corp | 285.5M | -57.3x | --- |
Enanta Pharmaceuticals Inc | 320.9M | -2.3x | --- |
G1 Therapeutics Inc | 234.7M | -7.3x | --- |
Rigel Pharmaceuticals Inc | 210.5M | -8.3x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $300.1M |
---|---|
Revenue (TTM) | $101.2M |
Shares Outstanding | 67.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-0.02 |
Book Value | $-0.70 |
P/E Ratio | -231.7x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 186.8x |
Operating Margin | -6.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.